Filing Details

Accession Number:
0001209191-20-042897
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-07-17 17:05:14
Reporting Period:
2020-07-15
Accepted Time:
2020-07-17 17:05:14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1658247 Crinetics Pharmaceuticals Inc. CRNX Pharmaceutical Preparations (2834) 263744114
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1746298 Scott Richard Struthers C/O Crinetics Pharmaceuticals, Inc.
10222 Barnes Canyon Road, Bldg 2
San Diego CA 92121
President & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-07-15 17,500 $15.30 908,305 No 4 S Indirect By Family Trust 1
Common Stock Disposition 2020-07-16 17,500 $14.46 890,805 No 4 S Indirect By Family Trust 1
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By Family Trust 1
No 4 S Indirect By Family Trust 1
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 100,000 Indirect By Family Trust 2
Common Stock 100,000 Indirect By Family Trust 3
Common Stock 100,000 Indirect By Family Trust 4
Footnotes
  1. Represents the weighted average sale price for the entire number of shares sold. The actual sales prices range between $14.95 and $15.76 per share. Information on the exact number of shares sold at each price can be obtained from the issuer upon request.
  2. Represents the weighted average sale price for the entire number of shares sold. The actual sales prices range between $14.10 and $15.34 per share. Information on the exact number of shares sold at each price can be obtained from the issuer upon request.